Journal
SCIENCE
Volume 316, Issue 5824, Pages 590-593Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1136031
Keywords
-
Categories
Funding
- Medical Research Council [MC_U137973817, MC_U137973816, MC_U137961143] Funding Source: Medline
- Medical Research Council [MC_U137973817, MC_U137961143, MC_U137973816] Funding Source: researchfish
- MRC [MC_U137973817, MC_U137961143, MC_U137973816] Funding Source: UKRI
Ask authors/readers for more resources
Clinically successful hematopoietic cell transplantation is dependent on hematopoietic stem and progenitor cells. Here we identify the matricellular protein Nephroblastoma Overexpressed (Nov, CCN3) as being essential for their functional integrity. Nov expression is restricted to the primitive (CD34) compartments of umbilical vein cord blood, and its knockdown in these cells by lentivirus-mediated RNA interference abrogates their function in vitro and in vivo. Conversely, forced expression of Nov and addition of recombinant Nov protein both enhance primitive stem and/or progenitor activity. Taken together, our results identify Nov ( CCN3) as a regulator of human hematopoietic stem or progenitor cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available